ENDRA Life Sciences Granted Third U.S. Patent for Non-Invasive Fat Assessment to Support TAEUS™ Clinical Product Targeting Non-Alcoholic Fatty Liver Disease

New U.S. Patent Issued for Non-Invasive Fat Assessment Recites System Claims and Further Strengthens ENDRA’s Strong Portfolio of Thermoacoustic Intellectual Property

Thank you for visiting Tailwinds Research. We are pleased to offer free research on select small and micro cap companies. However, FINRA regulations require all readers to sign onto our site. It is free to join and we hope you’ll take the time to do so.

To create an account please click on this link.

If you already have an account, please log in here.

LEAVE A REPLY